SPAC Presentation
Procaps at a Glance
Successful History of Growth and Diversification Over 43-years
MHRA
FDA U.S. FOOD & DRUG
ADMINISTRATION
Al
Development of
Differentiated Platform
FDA U.S. FOOD & DRUG
ADMINISTRATION
1977
Source: Procaps
MHRA certification
and FDA re-
certification
Expansion of 5 key
plants
FDA approval to
manufacture
pharmaceuticals
marketed in USA
2010
2012
Vertical Integration
+ Inorganic Growth
Acquisition of
RymcoMedical Rym co for single-
Single-Use Innovative Solutions.
use injectables
Laboratorios López
¡Comprometidos con la vida!
LOAD
Bk Biokemical
Acquisitions of
Lab Lopez and
Biokemical expand
CenAm presence
and scales
consumer health
Acquisition of
Eye-zul Eye-zul strengths
OTC eye-care
portfolio
2014
2016
Industry Consolidation and
Building Scale Through
Inorganic Growth
ⒸIFC
2018
PROCAPS
Developing 200+
new products to
drive future
expansion
IFC and Alejandro
Weinstein become
investors
2020
GROUP
*
Regional
Consolidation
9View entire presentation